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Existing risk prediction methods for elective
abdominal aortic aneurysm repair do not predict
short-term outcome following endovascular repair
Benjamin O. Patterson, BSc, Peter J. Holt, PhD, Robert Hinchliffe, MD, Ian M. Nordon, BSc,
Ian M. Loftus, MD, and Matt M. Thompson, MD, London, United Kingdom
Objective: Improving the safety of elective abdominal aortic aneurysm (AAA) repair has become an imperative. Five
well-described risk-scoring systems developed on open aneurysm repair (OR) were tested on a multicenter contemporary
sample of patients undergoing endovascular repair of AAA (EVR) to determine if they predicted 30-day morbidity and
mortality.
Methods: The Glasgow score (GAS), combined prognostic index (CPI), and its modification (M-CPI), the Leiden score
and the Vascular Biochemical and Haematological Outctome Model (VBHOM) score were studied using a retrospective
database of 846 patients. Thirty-day mortality and serious morbidity were used as end-points. A receiver-operator
characteristic curves was plotted and the area under this (known as the c-statistic) was calculated to determine
discriminatory ability of each model.
Results: Incidence of postoperative mortality was 2.2% and serious morbidity was 12.3%. All scores were predictive of
mortality except the Leiden score, which had a c-statistic of 0.603 (95% CI, 0.485-0.720; P .123). The VBHOM score
and the M-CPI had a c-statistic of 0.649 (95% CI, 0.514 -0.783; P .026) and 0.653 (95% CI, 0.544-0.763; P .026),
respectively. The best performing scores were the GAS and CPI, which had a c-statistic of 0.677 (95% CI, 0.559-0.795;
P  .008) and 0.679 (95% CI, 0.572-0.787; P  .007), respectively. No score effectively predicted morbidity.
Conclusion: None of the available scores predicted the outcome of EVR with enough accuracy to be recommended for
clinical use. To improve preoperative risk prediction in EVR validation of new systems is required, taking into account
morphologic features of the aneurysm to predict medium-term morbidity and re-intervention. (J Vasc Surg 2010;52:
25-30.)Despite improvements in surgical techniques and peri-
operative care over the last 50 years, the death rate follow-
ing the rupture of abdominal aortic aneurysms (AAAs) has
remained unchanged.1-3 Detection before rupture and
elective repair is the only way of reducing aneurysm-related
death at present. The risk and potential benefit of such
procedures must be considered to determine which pa-
tients will derive the most benefit.
A recent systematic review of risk scoring systems for
AAA repair suggested that although some systems showed
promise, none of the available methods were ideal andmost
had significant drawbacks.4 In addition, none of the sys-
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endovascular aneurysm repair (EVAR), which now forms a
significant and increasing proportion of aneurysm practice.
The aim of this study is to quantify the discriminative
ability of a number of available risk prediction models using
contemporary data. It discusses the challenges of develop-
ing and maintaining these systems and suggests ways in
which future models might be improved.
METHODS AND PATIENTS
Most cases were identified using a database compiled
for a parallel project using data from seven English vascular
centers encompassing the period 2004 to 2008. The six
centers were St George’s Vascular Institute, St Thomas’
Hospital London, Frimley Park Hospital, Hull, Notting-
ham, Bristol Royal, and Southampton. A master database
was constructed incorporating all of the data required for
the risk scoring systems. Risk scores were calculated using
previously published formulae.5-8 The inclusion criterion
was that all cases must be elective repair of infrarenal AAAs.
Exclusion criteria included emergency admissions (mainly
ruptured aneurysms), thoracoabdominal aneurysms, hybrid
revascularization procedures and any other non-abdominal
aortic aneurysm repair. For the purposes of these analyses,
mortality was defined as death with 30 days of primary proce-
dure, although late death was also recorded in the database.
Classification of morbidity was based on the ad hoc
Committee for Standardizing Reporting Practices in Vas-
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Association for Vascular Surgery.9 These included cardiac
complications (requiring medical intervention, ie, myocar-
dial infarction or cardiac failure), respiratory complications
(infection prolonging hospital stay), cerebrovascular event
(symptomatic or evidence on CT scan), postoperative limb
complication (such as major amputation or ischemia re-
quiring intervention), reoperation for aneurysm-related
complications, sepsis (documented infection), groin access
site complications (hematoma, pseudoaneurysm, lympho-
cele), ischemic bowel (requiring intervention), and deep
vein thrombosis or pulmonary embolism (requiring treat-
ment). Also included were anastamotic complications,
bleeding requiring transfusion, and wound dehiscence.
Rationale for prediction system selection. Five risk
scoring systems were selected to be validated using these
data. The Glasgow score (GAS), the combined prognostic
index (CPI) score, and its modified version (M-CPI) had
been previously validated in open aneurysm repair (OAR)
but were not reliable in predicting the outcome of
EVAR.7,10-12 Attempting to validate these three scores
using a multicenter, contemporary dataset using modern
stent grafts was performed to establish whether the pub-
lished performance was consistent across a larger EVAR
dataset in “real world” practice. The two other scoring
systems used were Vascular Biochemical and Haematologi-
cal Outctome Model (VBHOM) and the Leiden score.
These have both shown promise as accurate models when
applied to OAR, but neither have been validated for use in
EVAR to date.
The Physiological and Operative Severity Score for the
Enumeration ofMortality andMorbidity (POSSUM) scor-
ing system and derivatives were not used in this study.
Although useful in comparative audit, a systematic review
performed at our institution suggested that it has limited
potential as a practical preoperative tool to aid decision
making.4 It would have been useful to attempt to validate
the recently proposed Australian morphology-based risk
scoring system,13 but unfortunately there was insufficient
anatomic data available to do this across all cases.
Statistical analysis. Spreadsheets were initially con-
structed using EXCEL 2003 (Microsoft, Redmond, Wash)
incorporating the different data sources. Predictive scores
were calculated according to the original papers or most-
often utilized modification based on a review of the litera-
ture.4 Formulae written into the spreadsheet were used to
do this. All further statistical analysis was performed using
SPSS version 14 (SPSS Inc, Chicago, Ill).
The main comparator was the area under the curve
(referred to here as the “c-statistic”) of a plotted receiver-
operator characteristic (ROC) curve.14 An ROC curve uses
a visual representation of the sensitivity-specificity balance
to determine the ability of a test to predict the outcome of
an event with discrete outcomes. Sensitivity is plotted
against 1—specificity over the range of values for the test
being investigated. An ideal test would produce a curve that
would be a near-vertical upward phase turning sharply to
the horizontal near to point (0, 1) with an c-statistic closeto 1. A diagonal line from point (0, 0) to (1, 1) suggests the
test has a predictive power equivalent to chance alone with
a c-statistic of 0.5. The c-statistic derived from the curve
produces a value between 0.5 and 1. This represents the
probability that the test will predict an outcome in compar-
ison with random chance. Values from 0.70 to 0.50 denote
progressively poorer predictive power tending toward ran-
dom chance, with values over 0.80 indicating reliable accu-
racy. A statistical test of significance produces a P value
associated with the c-statistic. This tests the null hypothesis
that the c-statistic  0.5 and therefore is nondiscrimina-
tory. The point of the curve closest to the upper left of the
axis represents the point where the score achieves the best
balance of sensitivity and specificity. It is at this point that a
“cut-off” point can be defined. For example, when consid-
ering scores to predict the result of AAA repair, this would
be the value of the score that divides patients into high- and
low-risk subgroups.
Two methods of controlling for missing values were
used. For categorical variables, such as the presence or
absence of cerebrovascular disease, the assumption made
was that there was no cerebrovascular disease if these data
were not present. For numerical data such serum electrolyte
levels, a mean value from all samples was taken and this was
imputed into the spreadsheet.More complex approaches to
missingness were not utilized, such as multiple regression
or most likely value imputation. Confidence intervals were
calculated using the nonparametric asymptotic method.14
Tertile analysis was performed by calculating the tertiles
of each score and then calculating the 30-day mortality rate
for each subgroup. 2 testing was used to determine if there
was a significant difference between the mortality rate in
each tertile.
RESULTS
One thousand three hundred seventy-two patients un-
dergoing aneurysm repair between 2004 and 2009 in the
United Kingdom were identified from participating cen-
ters. Patient level data were obtained either at the time of
admission into local databases or retrospectively by search-
ing the medical record. Data were obtained from seven
vascular surgery centers (St George’s Vascular Institute, St
Thomas’ Hospital, Frimley Park Hospital, Hull, Notting-
ham, and Southampton, Bristol Royal Infirmary [all in
England]). Much of these data had been collected as part of
locally administered databases or as part of a parallel
project. On closer scrutiny of the data, 272 cases were
excluded. ThisOn closer scrutiny of the data was because
they were emergencies (148), the procedure type was not
recorded (55), or the procedure was not repair of an AAA
but other pathologies such as dissection, hybrid revascular-
ization, thoracic aneurysm repair, or iliac artery repair (46).
The remainder was excluded due to crucial missing data
such as missing mortality data (23). The final number of
cases was 1100 of which 846 were endovascular cases. They
were all “standard” infrarenal EVAR procedures with no
fenestrated or branched grafts being used.
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 1 Patterson et al 27The percentage of male patients in the EVAR was 89%
and the mean age of patients was 74 (41-95) years old
(Table I). Perioperative deaths were classed as those occur-
ring within 30 days of surgery. The mortality rate in the
group was 2.2% and the rate of major perioperative mor-
bidity was 12.2%.
Three of the scores were weakly discriminative for
30-day mortality, but all achieved statistical significance
Table I, a. Demographics of the patient group and
distribution of scores including missing values
Value
Missing
values
Male 753 (89%) 0
Hypertensive 394 (46.5%) 108 (12.8%)
Diabetes 55 (7%) 55 (6.5%)
Cerebrovascular disease 81 (10%) 108 (12.8%)
Cardiac disease 410 (48.5%) 1 (0.1%)
Congestive cardiac
failure 26 (3%) 74 (8.7%)
ASA 164 (19.4%)
1 11
2 109
3 486
4 76
Statin 511 (39.5%) 1 (0.1%)
-blocker 194 (22.9%) 0
Respiratory disease 149 (17.6%) 17 (2%)
Sodium 138.8 (114–172) mmol/L 69 (8.1%)
Potassium 4.3 (2.9–6.2) mmol/L 70 (8.3%)
Urea 7.2 (2.4–24.9) mmol/L 73 (8.6%)
Creatinine 109 (29–439) mol/L 15 (1.7%)
Hemoglobin 13.4 (5–18.7) g/dl 72 (8.5%)
White cell count 8.092 (2.4–37.5) x109/L 83 (9.8%)
Age at operation 74.7 (41–94)
Glasgow score 80.1 (41–111)
Leiden score 33.5 (18–53)
CPI 3.9 (25–46)
M-CPI 1.7 (25–36)
VBHOM 1.7 (4.78–3.76)
ASA, American Society of Anaesthesiologists peri-operative risk score; CPI,
combined prognostic index; M-CPI, modified combined prognostic index;
VBHOM, Vascular Biochemical and Haematological Outcome Model.
Table I, b. Incidence of postoperative complications
Groin complication 30 (3.5%)
Complications NOS 22 (2.6%)
Death within 30 days 19 (2.2%)
Postop MI 12 (1.4%)
Anastamotic complications 8 (1%)
Renal failure 8 (1%)
Early reoperation 8 (1%)
Significant postop bleeding requiring transfusion/
intervention 5 (0.6%)
Cardiac failure 4 (0.4%)
Venous thromboembolism 2 (0.2%)
Respiratory failure 2 (0.2%)
Limb ischemia 1 (0.1%)
Wound dehiscence 1 (0.1%)
Major morbidity 103 (12.2)
MI, Myocardial infarction; NOS, not otherwise specified.except for the Leiden score. Leiden score had a c-statistic of0.603 (95% CI, 0.485-0.720; P .123) and the VBHOM
score 0.649 (95% CI, 0.514-0.783; P  .026) and the
M-CPI 0.653 (95% CI, 0.544-0.763; P  .026). The best
performing scores were the GAS, which had a c-statistic of
0.677 (95% CI, 0.559-0.795; P .008) and the CPI score
with a c-statistic of 0.679 (95% CI, 0.572-0.787; P 
.007). The ROC curves are displayed in Fig 1 and Table II.
None of the scores showed an ability to predict major
morbidity. For the GAS, the c-statistic was 0.573 (95% CI,
0.517-0.628; P  .017), the Leiden score the c-statistic
was 0.580 (95% CI, 0.524-0.636; P  .009) and for the
VBHOM the c-statistic was 0.525 (95% CI, 0.475-0.575;
P  .026). The CPI and M-CPI appeared to have an
inverse relationship with the chances of sustaining major
morbidity with a c-statistic of 0.387 (95%CI, 0.331-0.444;
P  .000) and 0.402 (95% CI, 0.475-0.575; P  .001),
respectively. As the c-statistic in each case was less than 0.6,
this indicated that these scores fared no better than chance
alone in predicting morbidity (Table III). No formal mea-
sure of calibration of the models was undertaken. The
reason for this is that calculating the predicted mortality for
a group given their GAS is not possible, and there is no
formal way of converting the “raw score” version of the
CPI to a percentage mortality estimate. The VBHOM and
Leiden systems overestimated predicted mortality in this
group of patients.
Tertile analysis was performed to examine the stepwise
increase in mortality between groups at different strata of
predicted risk (Fig 2). For the GAS, the mortality rate
increased from 0.7% to 2.5% and 3.5% through each tertile
(2  5.84, 2 df; P  .054). The Leiden score morbidity
stayed at 1.8% until the third tertile when it increased to
3.2% (2 1.82, 2 df; P .402). The CPI score showed a
step-wise increase from 0.7% through 1.8% to 4.3% (2 
10.18, 2 df; P  .006) The M-CPI increased from 1% to
1.4% to 4.3% (2  7.84, 2 df; P  .0198). The VBHOM
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Fig 1. Receiver operator characteristic curve for mortality after
endovascular repair.score did not increase in a stepwise fashion ranging from 1%
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P  .248).
DISCUSSION
This study was designed to test the hypothesis that
previously described operative risk scoring systems would
not be useful in predicting the immediate postoperative
outcome following endovascular abdominal aortic aneu-
rysm repair using a larger, current, multicenter dataset. We
found that several previously described scores that pre-
dicted the outcome of open repair were not reliable predic-
tors of 30-day mortality and did not predict major morbid-
ity in our sample. However, the GAS and the CPI scoring
systems did show moderate discriminatory ability. Tertile
analysis demonstrated that although different risk groups
could be demonstrated, the absolute difference in risk
between these groups was not as great as was seen when
these scores were applied to OAR. The two CPI scores
showed statistically significant difference across centiles,
but the Leiden and VBHOM scores did not. The GAS
progression across the tertiles was nonsignificant by a small
margin. This is perhaps unsurprising given the lower mo-
rality rate associated with EVAR. In this context, distin-
guishing between groups of patients at 1% and 4% risk of
deathmay be of some use in clinical decisionmaking, as this
represents a four-fold increase in mortality.
AAA repair remains an intrinsically hazardous proce-
dure for a number of reasons. These include the invasive
nature of the interventional strategies available, the sys-
Table II. Area under the receiver-operator characteristic c
Test result variable(s) Area P
Glasgow score 0.677
Leiden score 0.603
CPI 0.679
M-CPI 0.653
VBHOM 0.649
CPI, Combined prognostic index; M-CPI, modified combined prognostic
All scores except the Leiden score achieved significance, but all had an area of
that true AUC  0.5, therefore of no discriminatory value.
Table III. Area under the receiver-operator characteristic
Test result variable(s) Area P
Glasgow score 0.573
Leiden score 0.580
CPI 0.387
M-CPI 0.402
VBHOM 0.525
CPI, Combined prognostic index; M-CPI, modified combined prognostic
All scores achieved significance but all had an area of 0.6 indicating mini
therefore of no discriminatory value.temic nature of aneurysmal arterial disease, and patientcomorbidities. Multicenter registry data have been used
previously to assess the ability of the GAS to predict mor-
tality following EVAR. Immediate postoperative death was
predicted with acceptable accuracy, obtaining a c-statistic
of 0.70010,11 with a sample size of 5498. Another score,
the “Comorbidity Severity Score of the Society for Vascular
Surgery and the American Association for Vascular Sur-
gery” yielded similarly poor results.15,16
In a recent comparison, the GAS, the V-POSSUM and
the customized probability index (CPI) were poor predic-
tors of postoperative mortality.12 A finding common to
many studies of risk scoring systems in EVAR is that no
scores appear to predict postoperative morbidity with any
degree of accuracy.
A possible explanation for the failure of existing scoring
systems to predict mortality after EVAR is that the imme-
diate postoperative death rate is significantly lower than
after open repair. Reintervention for graft-related compli-
cations is the main cause of morbidity, and this normally
occurs at a later stage. It is during the management of these
problems that the majority of major complications and
death due to EVAR occur.17,18 This poses several problems
when designing a potential risk scoring system for EVAR.
As postoperative adverse events are less common in EVAR,
then the number of cases required to generate sufficient
numbers to perform a meaningful analysis are very large. As
with all studies of long-term events outside the confines of
randomized clinical trials, the number of patients lost to
follow-up increases with time, so late complications would
for the five risk scoring systems for mortality
e
95% confidence interval
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0.572 0.787
0.544 0.763
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indicating suboptimal discriminatory ability. P values test the null hypothesis
e for the five risk scoring systems for morbidity
e
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mal dilikely be underrepresented in EVAR groups. A further
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specialist centers that are not necessarily the patient’s local
hospital. This means if the patient re-presents with a myo-
cardial infarction for example, it may not be recorded and
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Fig 2. Tertile analysis summarized. The x-axis represents the
value of the scores that divide each tertile. The y-axis represents the
percentage of patients who experienced in-hospital mortality
within each tertile.would not be incorporated into any further model.Another problem with development of any risk stratifica-
tion models in interventional procedures is that target popu-
lations change over time as the indications for intervention
expand in parallel with technologic advances. This means that
a model developed using historical data may not be applicable
to modern practice, and a current model tends to lose predic-
tive power over time, a process known as model drift. It is
important therefore that models be recalibrated at a regular
interval. This phenomenonhas beenwell described in the field
of interventional cardiology.19 Study demonstrates likely
model drift and inapplicability of a physiologic system to a
morphologic problem.
Limitations of this study include handling of missing
data. This particularly includes some patients that had data
regarding the presence of heart failure and cerebrovascular
disease missing. These features are components of the
Leiden score, the CPI, and the GAS. It is possible therefore
that not incorporating these into the scores could have led
to a poor estimation of some of the scores whichmight have
affected the discriminatory ability. Missing hematology and
biochemistry values were imputed by taking the mean value
of the sample. This might have lead to an underestimation
of the predictive power of the VBHOM.
It is recognized that patient selection for major inter-
ventions such as AAA repair is a complex decision. Facili-
tating this will potentially have some significant benefits for
patients and healthcare systems. Screening for AAAs inmen
over 65 is becoming routine in many countries. It is likely
that this will result in an increase in the number of elective
repairs annually in an average hospital by two per month,
increasing the cost to the health service.20 In these asymp-
tomatic younger individuals identified by the screening
program, it will be important to ensure surgery is as safe as
possible to ensure clinical and cost-effectiveness. Accurate
identification of patients most likely to survive surgery will
be one key aspect, as well as informing the process of
consent.
A new risk prediction system based on anatomical and
physiologic data is needed that will predict the immediate
and longer-term results of EVAR. The aims of such amodel
must be to allow surgeons to accurately predict the out-
comes of surgery and to reduce adverse postoperative
events including death. In some situations, this might mean
that patients must be counseled toward accepting a nonop-
erative management where anatomy and physiology are
adverse. Ideally, such a system might also help predict
which patients will need endovascular adjuncts in challeng-
ing anatomical situations to prevent specific graft-related
morbidities. This will improve patient safety by reducing
deaths, reinterventions, and may therefore improve cost-
effectiveness of EVAR.
In summary, these findings suggest that the GAS, Lei-
den, CPI, M-CPI, or VBHOM scoring systems should not
be used in routine practice to predict the outcome of
EVAR. To successfully predict medium or late events after
EVAR, a new scoring system will have to incorporate the
determinants of these events. Preoperative comorbidities
and physiologic measurements are probably relevant, but
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to play a key role. Further work should be aimed at deter-
mining which of these factors are significant and how they
can be used to predict the outcome of EVAR.
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